• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组织因子途径抑制物-α对凝血酶生成的组织因子非依赖性抑制作用。

Tissue factor-independent inhibition of thrombin generation by tissue factor pathway inhibitor-α.

机构信息

Department of Biochemistry, Maastricht University, Maastricht, The Netherlands.

出版信息

J Thromb Haemost. 2015 Jan;13(1):92-100. doi: 10.1111/jth.12766. Epub 2014 Nov 29.

DOI:10.1111/jth.12766
PMID:25348176
Abstract

BACKGROUND

Tissue factor pathway inhibitor-α (TFPIα) inhibits factor Xa by forming a binary TFPI-FXa complex in a reaction that is stimulated by protein S. TF-FVIIa forms a quaternary complex with TFPIα and FXa, which shuts off the initiation of coagulation via the extrinsic pathway.

AIM

To investigate whether direct inhibition of FXa by TFPIα independently of TF plays a role in downregulating coagulation.

METHODS

Inhibition of FXa by TFPIα in plasma was determined by measuring thrombin generation triggered with FXa, the FX activator from Russell's viper venom (RVV-X), FXIa, or FIXa. TF-independent anticoagulant activities of TFPIα and its cofactor, protein S, were quantified: (i) after neutralization of TFPIα and protein S with anti-TFPI or anti-protein S antibodies; and (ii) in TFPI-depleted or protein S-depleted plasmas supplemented with varying amounts of TFPIα or protein S.

RESULTS

Both anti-TFPI and anti-protein S antibodies enhanced thrombin generation in plasma triggered with RVV-X, FXa, FIXa, or FXIa. Anti-TFPI and anti-protein S antibodies decreased the lag time and increased the peak height of thrombin generation to the same extent, indicating that inhibition of FXa by TFPIα requires the presence of protein S. TFPIα and protein S titrations in TFPI-depleted or protein S-depleted plasma in which thrombin formation was initiated with triggers other than TF also revealed TF-independent anticoagulant activity of TFPIα, which was completely dependent on the presence of protein S.

CONCLUSION

Direct inhibition of FXa by TFPIα contributes to the downregulation of coagulation.

摘要

背景

组织因子途径抑制剂-α(TFPIα)通过与蛋白 S 共同作用形成一个二元 TFPI-FXa 复合物来抑制因子 Xa 的活性,该反应受到蛋白 S 的刺激。TF-FVIIa 与 TFPIα 和 FXa 形成一个四元复合物,通过外源性途径关闭凝血的起始。

目的

研究 TFPIα 对 FXa 的直接抑制作用是否独立于 TF 在下调凝血中的作用。

方法

通过测量 FXa 引发的凝血酶生成来确定 TFPIα 在血浆中对 FXa 的抑制作用,FXa 的 FX 激活剂来自罗素蝰蛇毒液(RVV-X)、FXIa 或 FIXa。TFPIα 及其辅助因子蛋白 S 的 TF 非依赖性抗凝活性通过以下两种方法进行量化:(i) 用抗 TFPI 或抗蛋白 S 抗体中和 TFPIα 和蛋白 S 后;(ii) 在 TFPI 耗尽或蛋白 S 耗尽的血浆中补充不同量的 TFPIα 或蛋白 S。

结果

抗 TFPI 和抗蛋白 S 抗体均增强了 RVV-X、FXa、FIXa 或 FXIa 引发的血浆中凝血酶的生成。抗 TFPI 和抗蛋白 S 抗体降低了凝血酶生成的延迟时间并同等程度地增加了凝血酶生成的峰值高度,表明 TFPIα 对 FXa 的抑制作用需要蛋白 S 的存在。TFPIα 和蛋白 S 在 TFPI 耗尽或蛋白 S 耗尽的血浆中的滴定,其中凝血酶形成的触发物不是 TF,也揭示了 TFPIα 的 TF 非依赖性抗凝活性,该活性完全依赖于蛋白 S 的存在。

结论

TFPIα 对 FXa 的直接抑制作用有助于下调凝血。

相似文献

1
Tissue factor-independent inhibition of thrombin generation by tissue factor pathway inhibitor-α.组织因子途径抑制物-α对凝血酶生成的组织因子非依赖性抑制作用。
J Thromb Haemost. 2015 Jan;13(1):92-100. doi: 10.1111/jth.12766. Epub 2014 Nov 29.
2
Inhibition of tissue factor:factor VIIa-catalyzed factor IX and factor X activation by TFPI and TFPI constructs.组织因子抑制物:TFPI 和 TFPI 构建体对因子 VIIa 催化的因子 IX 和因子 X 的激活作用。
J Thromb Haemost. 2014 Nov;12(11):1826-37. doi: 10.1111/jth.12713. Epub 2014 Oct 12.
3
Protein S is a cofactor for platelet and endothelial tissue factor pathway inhibitor-α but not for cell surface-associated tissue factor pathway inhibitor.蛋白 S 是血小板和血管内皮组织因子途径抑制剂-α的辅助因子,但不是细胞表面相关组织因子途径抑制剂的辅助因子。
Arterioscler Thromb Vasc Biol. 2014 Jan;34(1):169-76. doi: 10.1161/ATVBAHA.113.302655. Epub 2013 Nov 14.
4
Factor V Has Anticoagulant Activity in Plasma in the Presence of TFPIα: Difference between FV1 and FV2.在 TFPIα 的存在下,因子 V 在血浆中具有抗凝活性:FV1 和 FV2 之间的差异。
Thromb Haemost. 2018 Jul;118(7):1194-1202. doi: 10.1055/s-0038-1656549. Epub 2018 Jun 4.
5
Inhibitory effects of LDL-associated tissue factor pathway inhibitor.低密度脂蛋白相关组织因子途径抑制剂的抑制作用
Thromb Res. 2014 Jul;134(1):132-7. doi: 10.1016/j.thromres.2014.03.043. Epub 2014 Apr 1.
6
Novel insights into the regulation of coagulation by factor V isoforms, tissue factor pathway inhibitorα, and protein S.新型因子 V 异构体、组织因子途径抑制物α 和蛋白 S 对凝血的调控作用的新见解。
J Thromb Haemost. 2017 Jul;15(7):1241-1250. doi: 10.1111/jth.13665.
7
Activated factor X and thrombin formation triggered by tissue factor on endothelial cell matrix in a flow model: effect of the tissue factor pathway inhibitor.在流动模型中,组织因子在内皮细胞基质上引发的活化因子X和凝血酶形成:组织因子途径抑制剂的作用。
Blood. 1994 Aug 15;84(4):1132-42.
8
Regulation of coagulation by tissue factor pathway inhibitor: Implications for hemophilia therapy.组织因子途径抑制剂对凝血的调节:对血友病治疗的影响。
J Thromb Haemost. 2022 Jun;20(6):1290-1300. doi: 10.1111/jth.15697. Epub 2022 Mar 27.
9
Activated protein C, protein S, and tissue factor pathway inhibitor cooperate to inhibit thrombin activation.活化蛋白 C、蛋白 S 和组织因子途径抑制物协同抑制凝血酶的激活。
Thromb Res. 2023 Oct;230:84-93. doi: 10.1016/j.thromres.2023.08.012. Epub 2023 Aug 23.
10
A new regulatory function of activated factor V: inhibition of the activation by tissue factor/factor VII(a) of factor X.激活的因子 V 的新调节功能:抑制组织因子/因子 VII(a)对因子 X 的激活。
J Thromb Haemost. 2013 Mar;11(3):503-11. doi: 10.1111/jth.12126.

引用本文的文献

1
Plasma tissue factor activity in lung cancer patients predicts venous thromboembolism and poor overall survival.肺癌患者的血浆组织因子活性可预测静脉血栓栓塞和总体生存率低下。
Res Pract Thromb Haemost. 2024 Mar 1;8(2):102359. doi: 10.1016/j.rpth.2024.102359. eCollection 2024 Feb.
2
A sensitive tissue factor activity assay determined by an optimized thrombin generation method.一种优化的凝血酶生成法测定的敏感组织因子活性测定法。
PLoS One. 2023 Jul 19;18(7):e0288918. doi: 10.1371/journal.pone.0288918. eCollection 2023.
3
ZNF354C Mediated by DNMT1 Ameliorates Lung Ischemia-Reperfusion Oxidative Stress Injury by Reducing TFPI Promoter Methylation to Upregulate TFPI.
DNMT1 介导的 ZNF354C 通过减少 TFPI 启动子甲基化来上调 TFPI,从而减轻肺缺血再灌注氧化应激损伤。
Oxid Med Cell Longev. 2022 Jul 19;2022:7288729. doi: 10.1155/2022/7288729. eCollection 2022.
4
Protein S: a Multifunctional Anticoagulant.蛋白S:一种多功能抗凝剂。
Biomed Res Clin Pract. 2017 Dec;2(5). doi: 10.15761/BRCP.1000151. Epub 2017 Nov 20.
5
Knockdown of TFPI-Anchored Endothelial Cells Exacerbates Lipopolysaccharide-Induced Acute Lung Injury Via NF-κB Signaling Pathway.TFPI 锚定内皮细胞敲低通过 NF-κB 信号通路加重脂多糖诱导的急性肺损伤。
Shock. 2019 Feb;51(2):235-246. doi: 10.1097/SHK.0000000000001120.
6
Elevated Plasma Factor IXa Activity in Premenopausal Women on Hormonal Contraception.激素避孕的绝经前妇女血浆因子 IXa 活性升高。
Arterioscler Thromb Vasc Biol. 2018 Jan;38(1):266-274. doi: 10.1161/ATVBAHA.117.309919. Epub 2017 Nov 2.
7
The effect of corn trypsin inhibitor, anti-tissue factor pathway inhibitor antibodies and phospholipids on microvesicle-associated thrombin generation in patients with pancreatic cancer and healthy controls.玉米胰蛋白酶抑制剂、抗组织因子途径抑制物抗体及磷脂对胰腺癌患者和健康对照者微泡相关凝血酶生成的影响。
PLoS One. 2017 Sep 14;12(9):e0184579. doi: 10.1371/journal.pone.0184579. eCollection 2017.
8
Identification of a new regulatory axis for the specification of primitive myelopoiesis and definitive hematopoiesis.鉴定调控原始髓系细胞和定型造血的新调控轴。
FASEB J. 2018 Jan;32(1):183-194. doi: 10.1096/fj.201700166RR. Epub 2017 Sep 6.